ES2099159T3 - Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos. - Google Patents

Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos.

Info

Publication number
ES2099159T3
ES2099159T3 ES91911030T ES91911030T ES2099159T3 ES 2099159 T3 ES2099159 T3 ES 2099159T3 ES 91911030 T ES91911030 T ES 91911030T ES 91911030 T ES91911030 T ES 91911030T ES 2099159 T3 ES2099159 T3 ES 2099159T3
Authority
ES
Spain
Prior art keywords
preparation
lipase
medicines
new
dna sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911030T
Other languages
English (en)
Inventor
Gunnar Bjursell
Lars Blackberg
Peter Carlsson
Sven Enerback
Olle Hernell
Jeanette Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2099159T3 publication Critical patent/ES2099159T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVAS SECUENCIAS DE DNA, A NUEVAS PROTEINAS CODIFICADAS PARA DICHAS SECUENCIAS DE DNA, Y AL USO DE TALES PROTEINAS. LA INVENCION TAMBIEN PRESENTA VECTORES, TAL COMO CONSTRUCCIONES PLASMIDAS, QUE COMPRENDEN TALES SECUENCIAS DE DNA, QUE SON CAPACES DE EXPRESAR LA ENZIMA DESEADA. LA INVENCION TAMBIEN INCLUYE ORGANISMOS ANFITRIONES TRANSFECTADOS CON TALES CONSTRUCCIONES, POR EJEMPLO LEVADURA DE BACTERIAS, CELULAS DE MAMIFEROS, Y ANIMALES TRANSGENICAS. LA INVENCION TAMBIEN INCLUYE UN PROCESO PARA LA PREPARACION DE LOS NUEVOS PRODUCTOS DE LA INVENCION. LAS NUEVAS PROTEINAS ESTAN RELACIONADAS CON UNA ENZIMA, CONOCIDA COMO LIPASA ESTIMULADA POR LA SAL DE BILIS.
ES91911030T 1990-06-01 1991-05-30 Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos. Expired - Lifetime ES2099159T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
ES2099159T3 true ES2099159T3 (es) 1997-05-16

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911030T Expired - Lifetime ES2099159T3 (es) 1990-06-01 1991-05-30 Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos.

Country Status (44)

Country Link
EP (1) EP0535048B1 (es)
JP (1) JPH05507201A (es)
KR (1) KR100212411B1 (es)
CN (2) CN1075113C (es)
AP (1) AP207A (es)
AT (1) ATE151077T1 (es)
AU (1) AU651979B2 (es)
BG (1) BG61165B1 (es)
CA (1) CA2083396C (es)
CZ (1) CZ287470B6 (es)
DE (1) DE69125489T2 (es)
DK (1) DK0535048T3 (es)
DZ (1) DZ1503A1 (es)
EG (1) EG19937A (es)
ES (1) ES2099159T3 (es)
FI (1) FI114639B (es)
GR (1) GR3023618T3 (es)
HK (1) HK62497A (es)
HR (1) HRP920771B1 (es)
HU (1) HU215258B (es)
IE (1) IE911844A1 (es)
IL (1) IL98273A (es)
IS (1) IS1751B (es)
JO (1) JO1694B1 (es)
LT (1) LT4020B (es)
LV (1) LV10292B (es)
MA (1) MA22166A1 (es)
MY (1) MY111245A (es)
NO (1) NO322962B1 (es)
NZ (1) NZ238223A (es)
PH (1) PH30761A (es)
PL (1) PL166534B1 (es)
PT (1) PT97836B (es)
RO (1) RO114793B1 (es)
RU (1) RU2140983C1 (es)
SE (1) SE9001985D0 (es)
SG (1) SG48078A1 (es)
SK (1) SK281089B6 (es)
TN (1) TNSN91041A1 (es)
TW (1) TW221712B (es)
UA (1) UA39165C2 (es)
WO (1) WO1991018923A1 (es)
YU (1) YU49138B (es)
ZA (1) ZA913778B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
MX338426B (es) 2010-04-23 2016-04-15 Synageva Biopharma Corp Enzima de enfermedad del almacenamiento lisosomico.
DK2613798T4 (en) 2010-09-09 2018-04-16 Synageva Biopharma Corp USING LYSOSOMAL SUR LIPASE TO TREAT PATIENTS WITHOUT LYSOSOMAL SUR LIPASE
CA2812852A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
DK2629790T3 (en) * 2010-10-21 2016-10-24 Swedish Orphan Biovitrum Ab (Publ) Approach to increase growth rate of human babies
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3107684A (en) * 1983-07-01 1985-02-07 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
EP0535048B1 (en) 1997-04-02
HU215258B (hu) 1998-11-30
HRP920771B1 (en) 1999-10-31
AP9100270A0 (en) 1991-07-31
SK164491A3 (en) 1995-07-11
SE9001985D0 (sv) 1990-06-01
RO114793B1 (ro) 1999-07-30
GR3023618T3 (en) 1997-08-29
IL98273A0 (en) 1992-06-21
IL98273A (en) 2005-11-20
EP0535048A1 (en) 1993-04-07
NO924528D0 (no) 1992-11-24
CN1326782A (zh) 2001-12-19
HUT63184A (en) 1993-07-28
NZ238223A (en) 1993-05-26
JO1694B1 (en) 1992-08-09
FI925453L (fi) 1992-11-30
LTIP1736A (en) 1995-08-25
IE911844A1 (en) 1991-12-04
NO924528L (no) 1992-11-24
HRP920771A2 (en) 1997-04-30
DE69125489T2 (de) 1997-08-14
BG97123A (bg) 1993-12-24
HK62497A (en) 1997-05-16
CA2083396A1 (en) 1991-12-02
PT97836A (pt) 1992-02-28
CN1075113C (zh) 2001-11-21
CZ287470B6 (cs) 2000-12-13
DZ1503A1 (fr) 2004-09-13
FI925453A0 (fi) 1992-11-30
TNSN91041A1 (fr) 1992-10-25
KR100212411B1 (en) 1999-08-02
AU7964591A (en) 1991-12-31
CZ164491A3 (cs) 1999-07-14
PT97836B (pt) 1998-11-30
NO322962B1 (no) 2006-12-18
BG61165B1 (bg) 1997-01-31
WO1991018923A1 (en) 1991-12-12
SK281089B6 (sk) 2000-11-07
TW221712B (es) 1994-03-11
ATE151077T1 (de) 1997-04-15
SG48078A1 (en) 1998-04-17
IS1751B (is) 2000-07-21
DK0535048T3 (da) 1997-09-29
UA39165C2 (uk) 2001-06-15
EG19937A (en) 2000-12-31
PL166534B1 (pl) 1995-05-31
RU2140983C1 (ru) 1999-11-10
CN1064313A (zh) 1992-09-09
JPH05507201A (ja) 1993-10-21
ZA913778B (en) 1992-02-26
CA2083396C (en) 2006-09-19
PH30761A (en) 1997-10-17
LV10292B (en) 1995-08-20
AP207A (en) 1992-08-18
YU49138B (sh) 2004-03-12
FI114639B (fi) 2004-11-30
AU651979B2 (en) 1994-08-11
MY111245A (en) 1999-10-30
HU9203774D0 (en) 1993-03-29
IS3710A7 (is) 1991-12-02
MA22166A1 (fr) 1991-12-31
DE69125489D1 (de) 1997-05-07
YU95191A (sh) 1994-06-10
LV10292A (lv) 1994-10-20
LT4020B (en) 1996-08-26

Similar Documents

Publication Publication Date Title
EP0400958A3 (en) Live vaccines
Espreafico et al. Localization of myosin-V in the centrosome
Stringham et al. Targeted single‐cell induction of gene products in Caenorhabditis elegans: A new tool for developmental studies
EP0827410A4 (en) METHOD FOR THE INTRODUCTION AND EXPRESSION OF GENES IN ANIMAL CELLS
FI860015L (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
Kobayashi et al. Gene delivery to embryonic stem cells
CY1111267T1 (el) Διαγονιδιακα πτηνα και παραγωγη πρωτεϊνων
ES2110417T3 (es) Metodos y composiciones para la produccion de plantas de maiz fertiles, transformadas establemente y de sus celulas.
AU3936697A (en) Large scale production of human or animal proteins using plant bioreactors
ES2165434T3 (es) Virus atenuado de vacunacion y transferencia de genes, procedimiento de preparacion del virus y composiciones farmaceuticas que contienen el mismo.
ES8602133A1 (es) Un procedimiento para preparar un vector de transferencias de adn
YU128789A (sh) Postupak za dobijanje područja alkoholne oksidaze ii pichia pastoris-a
AU3679389A (en) Regulatory region of gene which is turned on at late stage in microbial growth cycle
RU94046200A (ru) Последовательности днк, производные последовательностей днк, плазмиды, способ применения последовательностей, способ применения плазмид, трансгенные растения
MX244498B (es) Recombinacion especifica de la secuencia de adn en celulas eucarioticas.
DE3681738D1 (es)
JO1694B1 (en) New chemical products
AR243605A1 (es) Un metodo para obtener protoporfirina ix del cultivo de microalgas eucarioticas del genero clamidomonas.
Echeverri et al. The Axolotl's journey to the modern molecular era
ES2062757T3 (es) Vector de clonacion para uso en bacterias de acido lactico y un metodo para construirlo.
Goudy et al. Simplified platform for mosaic in vivo analysis of cellular maturation in the developing heart
ES2043610T3 (es) Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.
Miljkovic et al. Cnidarian and bilaterian promoters can direct GFP expression in transfected hydra
ES8802401A1 (es) Un procedimiento para la preparacion de vesiculas de fosfoliptidos.
ES8702489A1 (es) Procedimiento para preparar un pseudooligosacarido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535048

Country of ref document: ES